The study in The Lancet journal found patients were 28 percent more likely to develop full blown AIDS, or die, if they deferred treatment until the point currently recommended in many countries.
Current guidelines call for treatment only after it's been shown there is damage to the immune system.
This team concluded that a count of 350 cells should be the minimum threshold for starting treatment.
